Breaks Categories: News

WednesdayDec 16, 2020 11:01 am

NetworkNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Announces Holiday ‘Artist Showcase’ Featuring Bigga$tate and Leeky Bandz

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced that two high-profile artists are making their debut on its flagship platform, Fan Pass. According to the update, Fan Pass announced its Holiday “Artist Showcase,” coming this weekend and featuring artist Bigga$tate on Friday, Dec. 18, and Leeky Bandz on Sunday, Dec. 20. Both artists have recently approved three custom merchandise designs created by the Fan Pass team, and each of the items will be added to the artists’ Merch store within each of their channels on the platform. “Our team has been working to assist each artist with…

Continue Reading

WednesdayDec 16, 2020 10:28 am

NetworkNewsBreaks – Innovative Payment Solutions Inc. (IPSI) to Expand into Global Digital Payment Infrastructures Through Strategic Joint Venture

Innovative Payment Solutions (OTCQB: IPSI), a U.S.-based fintech company building 21st century digital payment solutions, today announced the launch of a joint venture with blockchain and artificial intelligence company BLGI Inc. (OTCQB: BLGI). The joint venture will help expand IPSI into global digital payment infrastructures and ultimately advance the companies’ mutual efforts towards unlocking blockchain technology for swift funds processing, ensuring simplicity of payment for services at a substantially reduced cost for consumers and secure network to transfer funds anywhere in the world. “Our agreement with BLGI provides our companies with a tremendous opportunity to develop, evaluate and implement a…

Continue Reading

WednesdayDec 16, 2020 9:47 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Releases Results for 2020 AGSM Voting

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) has announced voting results from its annual general and special shareholder meeting (“AGSM”). The virtual-only meeting was held Tuesday, Dec. 15. Earlier this year, on Oct. 30, 2020, company management sent out an information circulate to shareholders for their consideration outlining the matters to be considered and approved during the meeting; all items on that list were approved by the required majority of votes. Included in the voting was the election of directors; the following individuals were voted in: Jeffrey J. Scott, Marc Bertrand, Nicholas G. Kirton, Caroline MacCallum and Jacques Dessureault.…

Continue Reading

WednesdayDec 16, 2020 8:30 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Closes IPO, Exercises Option to Purchase Additional Shares

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea, has announced the closing of its initial public offering (“IPO”). The IPO consisted of a total of 4,025,000 shares — 3,500,000 shares of common stock combined with 525,000 additional shares made available through the exercise of the underwriters’ option to purchase additional common stock shared. All the shares were offered at the price of $6 per share, and resulted in $24.15 million for the company, before underwiring discounts, commissions and other related expenses were deducted.…

Continue Reading

TuesdayDec 15, 2020 3:25 pm

NetworkNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) Marks Proud Milestone, Poised for More Opportunities

InsuraGuest Technologies (TSXV: ISGI), an innovative insurtech leader, is positioned amid new markets on the heels of its approval as a residential surplus lines provider. The company announced this pivotal moment in a press release on Nov. 5, 2020, indicating the license to offer surplus lines casualty and surplus lines property insurance in the state of Utah was granted to its wholly owned subsidiary InsuraGuest Insurance Agency LLC. A recent article discussing this reads, “The licensing will allow InsuraGuest to capitalize on this insurance sector while also opening up more market opportunities to sell additional products and create more revenue…

Continue Reading

TuesdayDec 15, 2020 2:37 pm

NetworkNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Announces Entry into Cannabis Productivity, Plans for Psychedelic Research and Development

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately held biopharma company, today announced its entry into the productivity phase of cannabis cultivation, micropropagation and extraction. The company also announced its preparation of a Health Canada application towards psychedelic research and development for a medicinal mushroom (Psilocybe semilanceata) Dealer Licence and a Section 56 Exemption for use of psilocybin production and extraction for planned preclinical research under scientific purposes, per the Controlled Drugs and Substances Act (the “CDSA”). According to the update, W2G has secured approval for a single-story production facility designed to support tissue culture and micropropagation and to meet organic…

Continue Reading

TuesdayDec 15, 2020 2:00 pm

NetworkNewsBreaks – Knightscope Inc.’s K5 ASRs Deploy at Houston Airport

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its deployment at the Houston Airport. According to the update, a pair of Knightscope K5 ASRs are now patrolling 24/7 at the George Bush Intercontinental Airport. In addition to enhancing safety and security, the deployment is planned to include robot-traveler interaction for assistance with vehicle issues such as dead batteries, flat tires and lockouts through two-way intercom call capabilities. To view the full update, visit https://nnw.fm/mRvo5 About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security…

Continue Reading

TuesdayDec 15, 2020 12:42 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Slated to Present at Leading Investor Forum

Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at the upcoming Life Sciences Investor Forum ("LSIF"). The leading proprietary investor conference is scheduled for Dec. 17, 2020, and is a live, interactive investor event held quarterly for public and private companies, investors and industry professionals from around the world. The daylong event features company presentations and interactive discussions about the life sciences sector. Pressure BioSciences president and CEO Richard T. Schumacher will be presenting at the forum. His presentation is scheduled for 11 a.m. ET and may include key highlights regarding the company’s three key technology platforms: Pressure Cycling…

Continue Reading

TuesdayDec 15, 2020 12:30 pm

NetworkNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Announces Successful Deployment of BolaWrap(R)

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced that police in the City of Beaufort, South Carolina safely subdued a subject using the BolaWrap Remote Restraint device. According to the update, the BolaWrap allowed the officers on the scene to take the subject into custody without injury to either themselves or the subject. “As the BolaWrap is carried by more and more agencies, both in the U.S. and internationally, we expect to continue to see examples where our technology enables officers to take subjects into custody safely and humanely. We take great pride in our role…

Continue Reading

TuesdayDec 15, 2020 12:12 pm

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Launches Regulation A+ Offering

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has launched a Regulation A+ equity crowd-funding campaign. The announcement follows the qualification by the U.S. Securities and Exchange Commission of BRSF’s Form 1-A offering. The intended purpose of the offering is to provide both accredited and non-accredited potential investors an opportunity to support the company in its efforts to more fully introduce its proprietary technologies to the neurology market. Through its Reg A+ offering, Brain Scientific will sell units at $9 each, with a minimum investment of $500. The units are comprised of five  shares of common stock and one…

Continue Reading